Unresolved disorder model. using A ATOM 181 CB AILE 22 5.349 5.105 24.038 0.58 10.22 C Unresolved disorder model. using A ATOM 182 CB BILE 22 5.280 5.029 24.021 0.42 11.67 C Unresolved disorder model. using A ATOM 183 CG1AILE 22 4.261 5.398 25.076 0.58 10.66 C Unresolved disorder model. using A ATOM 184 CG1BILE 22 4.232 5.361 25.079 0.42 12.48 C Unresolved disorder model. using A ATOM 185 CG2AILE 22 4.714 4.741 22.697 0.58 9.44 C Unresolved disorder model. using A ATOM 186 CG2BILE 22 4.620 4.479 22.764 0.42 16.51 C Unresolved disorder model. using A ATOM 187 CD1AILE 22 4.776 5.952 26.383 0.58 19.41 C Unresolved disorder model. using A ATOM 188 CD1BILE 22 3.394 6.578 24.765 0.42 10.96 C Unresolved disorder model. using A ATOM 291 CB AHIS 36 -12.813 -14.167 37.087 0.27 18.68 C Unresolved disorder model. using A ATOM 292 CB BHIS 36 -12.790 -14.175 37.051 0.73 19.13 C Unresolved disorder model. using A ATOM 293 CG AHIS 36 -13.591 -15.300 36.480 0.27 21.25 C Unresolved disorder model. using A ATOM 294 CG BHIS 36 -13.493 -15.274 36.296 0.73 22.43 C Unresolved disorder model. using A ATOM 295 ND1AHIS 36 -14.891 -15.582 36.857 0.27 19.25 N Unresolved disorder model. using A ATOM 296 ND1BHIS 36 -12.979 -15.976 35.244 0.73 24.25 N Unresolved disorder model. using A ATOM 297 CD2AHIS 36 -13.260 -16.191 35.517 0.27 22.40 C Unresolved disorder model. using A ATOM 298 CD2BHIS 36 -14.744 -15.769 36.459 0.73 25.50 C Unresolved disorder model. using A ATOM 299 CE1AHIS 36 -15.312 -16.620 36.141 0.27 20.18 C Unresolved disorder model. using A ATOM 300 CE1BHIS 36 -13.835 -16.852 34.796 0.73 25.39 C Unresolved disorder model. using A ATOM 301 NE2AHIS 36 -14.344 -17.009 35.329 0.27 22.94 N Unresolved disorder model. using A ATOM 302 NE2BHIS 36 -14.937 -16.758 35.517 0.73 25.42 N Unresolved disorder model. using A ATOM 675 CB AASP 85 -16.073 12.985 29.809 0.51 18.98 C Unresolved disorder model. using A ATOM 676 CB BASP 85 -15.923 12.810 29.766 0.49 18.55 C Unresolved disorder model. using A ATOM 677 CG AASP 85 -16.441 12.598 31.227 0.51 18.29 C Unresolved disorder model. using A ATOM 678 CG BASP 85 -16.060 14.245 30.178 0.49 19.56 C Unresolved disorder model. using A ATOM 679 OD1AASP 85 -17.432 11.859 31.403 0.51 25.21 O Unresolved disorder model. using A ATOM 680 OD1BASP 85 -16.947 14.908 29.609 0.49 31.18 O Unresolved disorder model. using A ATOM 681 OD2AASP 85 -15.754 13.019 32.197 0.51 31.45 O Unresolved disorder model. using A ATOM 682 OD2BASP 85 -15.270 14.664 31.064 0.49 21.99 O Unresolved disorder model. using A ATOM 812 CB ALEU 100 -5.036 -20.383 11.499 0.68 15.07 C Unresolved disorder model. using A ATOM 813 CB BLEU 100 -5.031 -20.403 11.459 0.32 13.99 C Unresolved disorder model. using A ATOM 814 CG ALEU 100 -3.626 -20.701 11.034 0.68 15.38 C Unresolved disorder model. using A ATOM 815 CG BLEU 100 -4.210 -21.201 10.443 0.32 14.61 C Unresolved disorder model. using A ATOM 816 CD1ALEU 100 -2.661 -21.067 12.147 0.68 29.30 C Unresolved disorder model. using A ATOM 817 CD1BLEU 100 -3.620 -22.410 11.150 0.32 21.88 C Unresolved disorder model. using A ATOM 818 CD2ALEU 100 -3.761 -21.859 10.029 0.68 20.80 C Unresolved disorder model. using A ATOM 819 CD2BLEU 100 -5.019 -21.616 9.239 0.32 15.50 C Unresolved disorder model. using A ATOM 836 CB AGLN 103 -4.228 -16.579 16.178 0.79 11.06 C Unresolved disorder model. using A ATOM 837 CB BGLN 103 -4.232 -16.530 16.159 0.21 12.01 C Unresolved disorder model. using A ATOM 838 CG AGLN 103 -3.663 -16.807 14.767 0.79 10.59 C Unresolved disorder model. using A ATOM 839 CG BGLN 103 -3.671 -17.586 17.086 0.21 15.88 C Unresolved disorder model. using A ATOM 840 CD AGLN 103 -2.271 -17.423 14.799 0.79 15.40 C Unresolved disorder model. using A ATOM 841 CD BGLN 103 -2.166 -17.542 17.163 0.21 15.13 C Unresolved disorder model. using A ATOM 842 OE1AGLN 103 -2.112 -18.425 15.496 0.79 25.45 O Unresolved disorder model. using A ATOM 843 OE1BGLN 103 -1.597 -17.338 16.094 0.21 10.92 O Unresolved disorder model. using A ATOM 844 NE2AGLN 103 -1.357 -16.925 14.022 0.79 12.93 N Unresolved disorder model. using A ATOM 845 NE2BGLN 103 -1.468 -17.725 18.272 0.21 13.37 N Unresolved disorder model. using A ATOM 1216 CB ASER 152 -23.908 -17.720 10.401 0.39 14.32 C Unresolved disorder model. using A ATOM 1217 CB BSER 152 -23.876 -17.602 10.432 0.61 15.29 C Unresolved disorder model. using A ATOM 1218 OG ASER 152 -24.023 -16.766 11.436 0.39 15.19 O Unresolved disorder model. using A ATOM 1219 OG BSER 152 -24.515 -18.758 10.913 0.61 20.26 O Unresolved disorder model. using A ATOM 1350 CB ALYS 170 0.999 -1.494 0.382 0.53 9.76 C Unresolved disorder model. using A ATOM 1351 CB BLYS 170 1.019 -1.431 0.374 0.47 14.05 C Unresolved disorder model. using A ATOM 1352 CG ALYS 170 1.476 -0.264 1.133 0.53 10.40 C Unresolved disorder model. using A ATOM 1353 CG BLYS 170 1.401 -0.195 1.182 0.47 15.65 C Unresolved disorder model. using A ATOM 1354 CD ALYS 170 2.837 -0.486 1.786 0.53 16.35 C Unresolved disorder model. using A ATOM 1355 CD BLYS 170 2.771 -0.412 1.835 0.47 12.69 C Unresolved disorder model. using A ATOM 1356 CE ALYS 170 3.920 -0.973 0.824 0.53 21.49 C Unresolved disorder model. using A ATOM 1357 CE BLYS 170 3.133 0.713 2.774 0.47 18.02 C Unresolved disorder model. using A ATOM 1358 NZ ALYS 170 5.248 -0.969 1.531 0.53 27.06 N Unresolved disorder model. using A ATOM 1359 NZ BLYS 170 4.335 0.422 3.602 0.47 24.71 N Unresolved disorder model. using A ATOM 1388 CB AASP 175 -15.510 4.995 -4.610 0.71 17.47 C Unresolved disorder model. using A ATOM 1389 CB BASP 175 -15.271 5.177 -4.689 0.29 16.12 C Unresolved disorder model. using A ATOM 1390 CG AASP 175 -16.673 5.828 -4.062 0.71 17.47 C Unresolved disorder model. using A ATOM 1391 CG BASP 175 -14.592 6.362 -5.337 0.29 14.89 C Unresolved disorder model. using A ATOM 1392 OD1AASP 175 -17.725 5.341 -3.572 0.71 17.52 O Unresolved disorder model. using A ATOM 1393 OD1BASP 175 -14.003 7.278 -4.709 0.29 17.48 O Unresolved disorder model. using A ATOM 1394 OD2AASP 175 -16.541 7.080 -4.121 0.71 25.30 O Unresolved disorder model. using A ATOM 1395 OD2BASP 175 -14.608 6.494 -6.580 0.29 16.26 O Unknown residue CMH: ATOM 1640 N CMH 206 -3.554 7.284 24.262 1.00 8.06 N Unknown residue CMH: ATOM 1641 CA CMH 206 -4.636 8.270 24.122 1.00 8.26 C Unknown residue CMH: ATOM 1642 C CMH 206 -6.021 7.642 24.158 1.00 7.99 C Unknown residue CMH: ATOM 1643 O CMH 206 -6.998 8.359 24.002 1.00 10.19 O Unresolved disorder model. using A ATOM 1644 CB ACMH 206 -4.634 8.963 22.743 0.71 10.59 C Unknown residue CMH: ATOM 1644 CB CMH 206 -4.634 8.963 22.743 0.71 10.59 C Unresolved disorder model. using A ATOM 1645 CB BCMH 206 -4.355 9.113 22.873 0.29 10.62 C Unresolved disorder model. using A ATOM 1646 SG ACMH 206 -3.038 9.401 22.101 0.71 13.01 S Unknown residue CMH: ATOM 1646 SG CMH 206 -3.038 9.401 22.101 0.71 13.01 S Unresolved disorder model. using A ATOM 1647 SG BCMH 206 -4.174 8.139 21.379 0.29 12.63 S Unresolved disorder model. using A ATOM 1648 CM ACMH 206 -1.354 11.570 25.391 0.71 30.72 C Unknown residue CMH: ATOM 1648 CM CMH 206 -1.354 11.570 25.391 0.71 30.72 C Unresolved disorder model. using A ATOM 1649 HG ACMH 206 -2.084 10.645 23.821 0.71 17.07 HG Unknown residue CMH: ATOM 1649 HG CMH 206 -2.084 10.645 23.821 0.71 17.07 HG Unresolved disorder model. using A ATOM 1705 CB ALYS 213 -19.381 -9.019 26.281 0.22 13.53 C Unresolved disorder model. using A ATOM 1706 CB BLYS 213 -19.344 -9.006 26.302 0.78 13.01 C Unresolved disorder model. using A ATOM 1707 CG ALYS 213 -19.810 -10.440 26.620 0.22 19.09 C Unresolved disorder model. using A ATOM 1708 CG BLYS 213 -19.444 -10.499 26.720 0.78 16.51 C Unresolved disorder model. using A ATOM 1709 CD ALYS 213 -20.982 -10.523 27.585 0.22 22.34 C Unresolved disorder model. using A ATOM 1710 CD BLYS 213 -19.991 -10.669 28.107 0.78 21.97 C Unresolved disorder model. using A ATOM 1711 CE ALYS 213 -21.438 -11.972 27.773 0.22 22.96 C Unresolved disorder model. using A ATOM 1712 CE BLYS 213 -20.193 -12.129 28.467 0.78 25.39 C Unresolved disorder model. using A ATOM 1713 NZ ALYS 213 -22.893 -12.177 27.494 0.22 24.23 N Unresolved disorder model. using A ATOM 1714 NZ BLYS 213 -19.148 -13.024 27.888 0.78 46.13 N Unresolved disorder model. using A ATOM 1743 CB ASER 217 -21.102 -15.286 13.498 0.69 13.20 C Unresolved disorder model. using A ATOM 1744 CB BSER 217 -21.156 -15.212 13.624 0.31 10.83 C Unresolved disorder model. using A ATOM 1745 OG ASER 217 -21.202 -15.855 14.814 0.69 16.02 O Unresolved disorder model. using A ATOM 1746 OG BSER 217 -20.868 -16.340 12.808 0.31 16.03 O Unresolved disorder model. using A ATOM 1764 CB ASER 220 -14.944 -20.282 6.763 0.80 11.73 C Unresolved disorder model. using A ATOM 1765 CB BSER 220 -14.829 -20.280 6.706 0.20 12.47 C Unresolved disorder model. using A ATOM 1766 OG ASER 220 -13.649 -20.672 6.395 0.80 13.37 O Unresolved disorder model. using A ATOM 1767 OG BSER 220 -15.678 -20.803 5.696 0.20 12.26 O Unresolved disorder model. using A ATOM 2059 CB AGLN 255 -9.192 -1.507 37.346 0.68 18.73 C Unresolved disorder model. using A ATOM 2060 CB BGLN 255 -9.208 -1.562 37.350 0.32 18.20 C Unresolved disorder model. using A ATOM 2061 CG AGLN 255 -8.401 -1.825 38.637 0.68 17.39 C Unresolved disorder model. using A ATOM 2062 CG BGLN 255 -10.285 -2.571 37.659 0.32 22.01 C Unresolved disorder model. using A ATOM 2063 CD AGLN 255 -9.273 -1.573 39.849 0.68 16.97 C Unresolved disorder model. using A ATOM 2064 CD BGLN 255 -9.887 -3.910 38.235 0.32 26.54 C Unresolved disorder model. using A ATOM 2065 OE1AGLN 255 -10.058 -0.620 39.818 0.68 25.59 O Unresolved disorder model. using A ATOM 2066 OE1BGLN 255 -8.883 -4.085 38.916 0.32 37.87 O Unresolved disorder model. using A ATOM 2067 NE2AGLN 255 -9.129 -2.383 40.902 0.68 19.30 N Unresolved disorder model. using A ATOM 2068 NE2BGLN 255 -10.758 -4.912 37.991 0.32 26.50 N Chain identifier should be blank not A: ATOM 2118 ZN ZN A 741 -6.736 -1.597 15.292 1.00 6.74 ZN 1